Therapeutic Asset Ratings
25,363 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Duloxetine
Pain
Yan Yang, MD, Ph.D
P4
BBB
(73)
Entecavir
Hepatitis B Virus Infection
Sun Yat-sen University
P4
BBB
(73)
Enzalutamide
Castration-Resistant Prostate Carcinoma
Prostate Cancer Clinical Trials Consortium
P4
BBB
(73)
Enzalutamide
Prostate Carcinoma
Pfizer
P4
BBB
(73)
ETOPOSIDE
Burkitt Lymphoma
AIDS Malignancy Consortium
P4
BBB
(73)
ETOPOSIDE
Enteropathy-Associated T-Cell Lymphoma
Eric Jacobsen, MD
P4
BBB
(73)
ETOPOSIDE
Hemophagocytic Syndrome
Beijing Tongren Hospital
P4
BBB
(73)
ETOPOSIDE
Hemophagocytic Lymphohistiocytosis
Beijing Tongren Hospital
P4
BBB
(73)
ETOPOSIDE
Hepatosplenic T-Cell Lymphoma
City of Hope Medical Center
P4
BBB
(73)
ETOPOSIDE
Primary Central Nervous System Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P4
BBB
(73)
ETOPOSIDE
Primary Mediastinal Large B-Cell Lymphoma
University of Washington
P4
BBB
(73)
Everolimus
Estrogen-Receptor Positive Breast Cancer
UNC Lineberger Comprehensive Cancer Center
P4
BBB
(73)
EXEMESTANE
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)
P4
BBB
(73)
FLORTAUCIPIR
Alzheimer Disease
Eli Radiopharma
P4
BBB
(73)
FLORTAUCIPIR
Frontotemporal Dementia
Mayo Clinic
P4
BBB
(73)
Fludarabine
Leukemia, B-cell
Beijing Immunochina Medical Science & Technology Co., Ltd.
P4
BBB
(73)
Fludarabine
Beta-Thalassemia Major
M.D. Anderson Cancer Center
P4
BBB
(73)
FLUOROURACILUM
Gastric Neoplasm
Seagen, a wholly owned subsidiary of Pfizer
P4
BBB
(73)
Iloperidone
Bipolar I Disorder
Vanda Pharmaceuticals
P4
BBB
(73)
Iloperidone
Schizophrenia
Vanda Pharmaceuticals
P4
BBB
(73)
Irinotecan
Colorectal Neoplasm
Shanghai Zhongshan Hospital
P4
BBB
(73)
Irinotecan
Fallopian Tube Neoplasms
Eli Lilly and Company
P4
BBB
(73)
Irinotecan
Metastatic Neoplasm
Eli Lilly and Company
P4
BBB
(73)
LAMOTRIGINE
Bipolar I Disorder
Bristol-Myers Squibb
P4
BBB
(73)
LENVATINIB
Portal Vein Thrombosis
First Hospital of China Medical University
P4
BBB
(73)
Showing 426 to 450 of 25,363 assets
Previous
Page 18 of 1015
Next